Cramer cites 3 reasons why the market rallied on a day it had no business doing so

Cramer cites 3 reasons why the market rallied on a day it had no business doing so


Wall Street should have been down Tuesday, yet the stock market had a great run.

The usual suspects — tons of negative analyst notes, rising bond yields, mixed earnings, light housing data and spiking commodity prices — all lined up against the market Tuesday. Not to mention, St. Louis Federal Reserve Bank President James Bullard’s comments a day earlier that a 75-basis point interest rate hike could be a possibility at an upcoming policy meeting to accelerate the central bank’s fight against inflation.

“If the usual suspects all have alibis, what can explain today’s unexpected rally,” CNBC’s Jim Cramer said on Tuesday’s “Mad Money.” “I think we tend to underestimate our advantages,” he added.

Cramer listed three primary reasons for what he called the “bizarre action” in the market.

  1. The market was oversold, which makes it harder for stocks to plummet.
  2. Cramer recalled 1994 when the Fed doubled rates and stocks still rallied. If history is any indicator, Bullard’s tough talk might not be so bad after all, he said.
  3. Another reason for the market’s resilience Tuesday, according to Cramer, is the U.S. being in a better position than other countries, pointing to America’s reopening economy and reliable energy sources.

While inflation is admittedly a problem, Cramer’s got an answer for that, too.

“We got higher flank steak prices, more expensive corn flakes and bigger gasoline bill, but we also have much higher wages to combat the pain,” he said.



Source

Why a niche category of CRE lending is suddenly seeing record deals
Business

Why a niche category of CRE lending is suddenly seeing record deals

Wepro | Moment | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight […]

Read More
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Business

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity drug market won’t hinge on drugs that deliver greater weight loss alone.  Top executives from drugmakers big and small told CNBC that the next phase […]

Read More
Advisors to the ultra rich say AI isn’t a gamechanger for landing new clients
Business

Advisors to the ultra rich say AI isn’t a gamechanger for landing new clients

D3sign | Moment | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Market data firms have been pitching artificial intelligence as the key to locating elusive ultra-high-net-worth clients. But […]

Read More